Anti-interleukin-5 therapy (mepolizumab) in life-threatening asthma attack: A case-based discussion

MLA

T Böselt, et al. “Anti-Interleukin-5 Therapy (Mepolizumab) in Life-Threatening Asthma Attack: A Case-Based Discussion.” Respiratory Medicine Case Reports, vol. 28, Jan. 2019, p. 100927. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0e2226e4258cc3d301728a4130ff5556&authtype=sso&custid=ns315887.

APA

T Böselt, Timm Greulich, Peter Alter, Manuel J. Richter, Marco Idzko, Andreas Hoffmann, Roland Buhl, Khodr Tello, Andreas Rembert Koczulla, Stefan Kuhnert, Claus Vogelmeier, Björn Beutel, & Angelique Holland. (2019). Anti-interleukin-5 therapy (mepolizumab) in life-threatening asthma attack: A case-based discussion. Respiratory Medicine Case Reports, 28, 100927.

Chicago

T Böselt, Timm Greulich, Peter Alter, Manuel J. Richter, Marco Idzko, Andreas Hoffmann, Roland Buhl, et al. 2019. “Anti-Interleukin-5 Therapy (Mepolizumab) in Life-Threatening Asthma Attack: A Case-Based Discussion.” Respiratory Medicine Case Reports 28 (January): 100927. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0e2226e4258cc3d301728a4130ff5556&authtype=sso&custid=ns315887.